Related Experiment Video
Updated: Jul 10, 2026

Using Herbal-Cake-Separated Moxibustion for the Treatment of Rats with Chronic Renal Failure
Published on: December 22, 2023
Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis
M Tahmaz1, B Kumbasar, K Ergen
1Department of Internal Medicine and Nephrology, Haseki Research and Training Hospital, Istanbul, Turkey.
Abstract:
Fenofibrate, a fibric acid derivative, is used to treat diabetic dyslipidemia, hypertriglyceridemia, and combined hyperlipidemia alone or in combination with statins. Rhabdomyolysis is defined as a pathological condition of skeletal muscle cell damage leading to the release of toxic intracellular material into the circulation. Its major causes include trauma, ischemia, toxins, metabolic disorders, infections, and drugs. Rhabdomyolysis associated with fenofibrate is extremely rare. In nearly all of the presented cases, there was a predisposing factor for rhabdomyolysis such as diabetes, older age, renal insufficiency, and hypothyroidism. Here, we report a nondiabetic, nonhypothyroidic young female patient without any known prior renal disease presenting with acute renal failure developing after fenofibrate treatment.
Related Concept Videos
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute Kidney Injury I: Introduction
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Renal Drug Excretion: Tubular Secretion